Abion Inc. Share Price

A203400

KR7203400007

Biotechnology & Medical Research

End-of-day quote Korea S.E. 14/08/2026			5-day change	1st Jan Change
3,380.00 ^KRW	-2.03%		-.--%	-78.40%

04-07	ABION Announces Preclinical Data Showing IFN-? Antibody Fusion Abn202 Outperforms Trop2-Targeting ADCs	CI
04/04/25	Abion To Divest 5.9 Billion Won Worth Of Shares In Vivozon Inc	RE

ABION Inc. is a Korea-based company principally engaged in the research, development and sales of pharmaceuticals. Along with its subsidiaries, the Company operates its business through four segments including product segment, contract research organization (CRO) service segment, research segment and other segment. The Product segment produces and sells diagnostic reagents, research reagents, and stem cell culture medium. The CRO Service segment provides histopathology analysis, molecular genetic analysis, cellular immunoassay, and antibody detection services. The Research segment is engaged in research and development of drugs for protein therapeutics, nucleic acid therapeutics, and antibody therapeutics.

Employees

Sector

Biotechnology & Medical Research

More about the company

Stock Market
Stocks
A203400 Stock

Market Cap	60.91B 45.53M 41.03M 37.91M 34.27M 64.83M 4.27B 66.43M 454M 181M 2.29B 171M 167M 7.28B	P/E 2024	-4.02x	P/E 2025	-7.21x
Enterprise Value	32.57B 24.35M 21.94M 20.27M 18.33M 34.67M 2.28B 35.53M 243M 96.84M 1.22B 91.38M 89.43M 3.89B	EV / Sales 2024	282x	EV / Sales 2025	288x
Free-Float	73.67%	Yield 2024 *	-	Yield 2025	-

04-07	ABION Announces Preclinical Data Showing IFN-? Antibody Fusion Abn202 Outperforms Trop2-Targeting ADCs	CI
04/04/25	Abion To Divest 5.9 Billion Won Worth Of Shares In Vivozon Inc	RE
29/12/24	Nuon Co., Ltd. completed the acquisition of 4.06% stake in ABION Inc. from KPM TECH Co., Ltd..	CI
25/12/24	KPM TECH Co., Ltd. announced that it has received KRW 5.999999711 billion in funding from ABION Inc.	CI
22/12/24	Nuon Co., Ltd. agreed to acquire 4.06% stake in ABION Inc. from KPM TECH Co., Ltd. for KRW 8 billion.	CI
22/12/24	ABION Inc. announced that it has received KRW 8.0011152 billion in funding from TELCON RF PHARMACEUTICAL. Inc.	CI
17/12/24	KPM TECH Co., Ltd. announced that it expects to receive KRW 5.999999711 billion in funding from ABION Inc.	CI
04/12/24	ABION Inc. completed the acquisition of 7.56% stake in Vivozon, Inc. from TELCON RF PHARMACEUTICAL. Inc..	CI
04/12/24	ABION Inc. announced that it has received KRW 20.019993378 billion in funding from TELCON RF PHARMACEUTICAL. Inc.	CI
10/11/24	ABION Inc. announced that it expects to receive KRW 20.019993378 billion in funding from TELCON RF PHARMACEUTICAL. Inc.	CI
10/11/24	ABION Inc. agreed to acquire 7.56% stake in Vivozon, Inc. from TELCON RF PHARMACEUTICAL. Inc. for KRW 20.1 billion.	CI
27/10/24	ABION Inc. announced that it expects to receive KRW 9.999995616 billion in funding from TELCON RF PHARMACEUTICAL. Inc.	CI
27/12/23	Abion Inc. announced that it has received KRW 7.999997049 billion in funding from TELCON RF PHARMACEUTICAL. Inc., Gencurix Inc.	CI

1 day	-2.03%
3 months	-31.02%
6 months	-70.29%
Current year	-78.40%

Current year	2,850	21,675
1 year	2,850	22,550
3 years	2,850	36,388.89
5 years	2,850	46,666.67
10 years	2,850	73,472.22

Manager	Title	Age	Since
Young-Gi Shin CEO	Chief Executive Officer	55	31/07/2010
Seong-Yun Woo DFI	Director of Finance/CFO	45	27/03/2025
Gi-Ryong Jang COO	Chief Operating Officer	46	31/12/2025

Abion Inc. Share Price

Stocks

A203400

KR7203400007

Biotechnology & Medical Research

Valuation: Abion Inc.

Chart: Abion Inc.

Latest news: Abion Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Abion Inc.

Latest insider transactions

Bio Therapeutic Drugs

Financials

Company Profile

Director	Title	Age	Since
Young-Gi Shin BRD	Director/Board Member	55	30/12/2014
Jin-Wook Yang BRD	Director/Board Member	56	24/03/2022
Geun-Chul Park BRD	Director/Board Member	70	-

Date	Insider	Type	Quantity	% Market Cap.	Importance
08/12/25	Sun-mi Chang	Free	27	0.0001%	-
08/12/25	Yang-mi Lim	Buy	115	0.0002%
08/12/25	Yang-mi Lim	Free	92	0.0002%	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ABION INC.	-2.03%	-.--%	-71.30%	-80.44%	45.53M
WUXI APPTEC CO., LTD.	-1.06%	-0.07%	+60.76%	+68.61%	67.53B
ARGENX SE	+1.07%	+8.39%	+13.62%	+92.13%	60.74B
LONZA GROUP AG	+0.20%	-1.22%	+19.76%	+97.91%	55.66B
BEONE MEDICINES AG	-0.95%	+11.17%	+22.21%	+110.93%	47.97B
IQVIA HOLDINGS INC.	-0.23%	+4.07%	+25.63%	+40.08%	45.24B
REVOLUTION MEDICINES, INC.	-6.40%	-9.51%	+181.99%	+816.79%	39.08B
CELLTRION, INC.	+1.97%	+3.50%	+25.78%	+50.98%	35.34B
GENMAB A/S	-1.92%	-3.36%	+78.73%	+55.58%	33.45B
INSMED INCORPORATED	+1.05%	+9.77%	-37.66%	+408.42%	26.49B
Average	-0.12%	-0.43%	+31.95%	+166.10%	41B
Weighted average by Cap.	+0.02%	+1.64%	+43.52%	+168.18%

	2024	2025
Net sales	760M 568K 512K 473K 427K 809K 53.26M 829K 5.67M 2.26M 28.52M 2.13M 2.09M 90.77M	880M 658K 593K 548K 495K 937K 61.7M 960K 6.56M 2.62M 33.04M 2.47M 2.42M 105M
Net income	-43.38B -32.42M -29.22M -27M -24.41M -46.18M -3.04B -47.32M -324M -129M -1.63B -122M -119M -5.18B	-29.06B -21.72M -19.58M -18.09M -16.35M -30.94M -2.04B -31.7M -217M -86.4M -1.09B -81.53M -79.79M -3.47B
Net Debt	14.05B 10.5M 9.46M 8.74M 7.9M 14.95M 985M 15.32M 105M 41.76M 527M 39.4M 38.56M 1.68B	-28.33B -21.18M -19.09M -17.63M -15.94M -30.16M -1.99B -30.9M -211M -84.23M -1.06B -79.48M -77.79M -3.39B